Danielle M Townsley Selected Research

eltrombopag

1/2021	Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemia.
12/2020	Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome.
1/2020	Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.
1/2019	Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ.
1/2019	Eltrombopag promotes DNA repair in human hematopoietic stem and progenitor cells.
1/2019	Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag.
1/2018	Eltrombopag mobilizes iron in patients with aplastic anemia.
1/2017	Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.
12/2016	Nontransplant therapy for bone marrow failure.
1/2015	Eltrombopag in aplastic anemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Danielle M Townsley Research Topics

Disease

15	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 07/2013
6	Bone Marrow Failure Disorders 01/2019 - 07/2013
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2020 - 01/2016
4	Cytopenia 12/2020 - 01/2016
3	Neoplasms (Cancer) 01/2022 - 01/2018
3	Liver Diseases (Liver Disease) 01/2019 - 10/2014
2	Fibrosis (Cirrhosis) 12/2020 - 01/2018
2	Thrombocytopenia (Thrombopenia) 12/2020 - 07/2013
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2013 - 07/2013
1	Disease Progression 10/2020
1	Genomic Instability 01/2019
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 07/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Alcoholic Fatty Liver 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Aneuploidy (Aneuploid) 12/2017
1	Muscle Cramp (Cramp) 05/2016
1	Immune System Diseases (Immune Disorders) 12/2015
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 10/2014
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2014
1	Serum Sickness 09/2014
1	Cytokine Release Syndrome 09/2014
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2014
1	Sickle Cell Anemia (Hemoglobin S Disease) 07/2013
1	Thrombotic Thrombocytopenic Purpura 07/2013
1	Hemorrhage 07/2013
1	Hemolysis 07/2013
1	Pre-Eclampsia (Preeclampsia) 07/2013
1	HELLP Syndrome 07/2013
1	Anemia 07/2013
1	Iron Deficiencies 07/2013

Drug/Important Bio-Agent (IBA)

12	eltrombopag FDA Link 01/2021 - 07/2013
4	Thrombopoietin (c-mpl Ligand)IBA 12/2020 - 07/2013
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021 - 09/2014
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 01/2015
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 10/2014
3	MicroRNAs (MicroRNA)IBA 01/2018 - 12/2015
2	Thrombopoietin ReceptorsIBA 12/2020 - 01/2017
2	CytokinesIBA 01/2019 - 09/2014
2	AntibodiesIBA 07/2018 - 09/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 12/2016
2	IronIBA 01/2018 - 07/2013
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	Danazol (Azol)FDA LinkGeneric 12/2016 - 05/2016
2	EnzymesIBA 05/2016 - 07/2013
2	Pharmaceutical PreparationsIBA 01/2015 - 03/2014
1	durvalumabIBA 01/2022
1	tremelimumabIBA 01/2022
1	Reticulin (Reticular Fiber)IBA 12/2020
1	Monoclonal AntibodiesIBA 10/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	InterferonsIBA 01/2019
1	aerolysinIBA 07/2018
1	Proteins (Proteins, Gene)FDA Link 07/2018
1	RNA (Ribonucleic Acid)IBA 12/2017
1	Small Cytoplasmic RNAIBA 12/2017
1	Methotrexate (Mexate)FDA LinkGeneric 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016
1	telomerase RNA (bTR)IBA 10/2014
1	Immunoglobulin M (IgM)IBA 09/2014
1	thymoglobulin FDA Link 09/2014
1	Inosine Triphosphate (ITP)IBA 07/2013
1	thiamine triphosphorate (TTP)IBA 07/2013
1	romiplostim FDA Link 07/2013

Therapy/Procedure

6	Therapeutics 01/2022 - 12/2015
1	Intravenous Infusions 10/2020
1	Transplantation 01/2019
1	Aftercare (After-Treatment) 01/2018
1	Stem Cell Transplantation 01/2016
1	Platelet Transfusion (Blood Platelet Transfusions) 07/2013